iguratimod has been researched along with Experimental Hepatoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, Y; Furukawa, K; Haruki, K; Ishii, Y; Iwase, R; Sakamoto, T; Shiba, H; Shirai, Y; Yanaga, K | 1 |
1 other study(ies) available for iguratimod and Experimental Hepatoma
| Article | Year |
|---|---|
Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production.
Topics: Animals; Antirheumatic Agents; Chromones; Coculture Techniques; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-8; Liver Neoplasms, Experimental; Male; Neovascularization, Pathologic; Rats; Rats, Inbred F344; Sulfonamides | 2016 |